These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 29949465)
21. Self-Assembled Core-Shell-Type Lipid-Polymer Hybrid Nanoparticles: Intracellular Trafficking and Relevance for Oral Absorption. Li Q; Xia D; Tao J; Shen A; He Y; Gan Y; Wang C J Pharm Sci; 2017 Oct; 106(10):3120-3130. PubMed ID: 28559042 [TBL] [Abstract][Full Text] [Related]
22. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability. He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310 [TBL] [Abstract][Full Text] [Related]
23. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa. Makhlof A; Werle M; Tozuka Y; Takeuchi H J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935 [TBL] [Abstract][Full Text] [Related]
25. Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium. des Rieux A; Ragnarsson EG; Gullberg E; Préat V; Schneider YJ; Artursson P Eur J Pharm Sci; 2005; 25(4-5):455-65. PubMed ID: 15946828 [TBL] [Abstract][Full Text] [Related]
26. [Construction of Oral Insulin-Loaded Solid Lipid Nanoparticles and Their Intestinal Epithelial Cell Transcytosis Study]. Zheng YX; He Q; Xu M; Huang Y Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):570-576. PubMed ID: 34323033 [TBL] [Abstract][Full Text] [Related]
27. Studies on lactoferrin nanoparticles of gambogic acid for oral delivery. Zhang ZH; Wang XP; Ayman WY; Munyendo WL; Lv HX; Zhou JP Drug Deliv; 2013 Feb; 20(2):86-93. PubMed ID: 23495734 [TBL] [Abstract][Full Text] [Related]
28. Size-dependent absorption mechanism of polymeric nanoparticles for oral delivery of protein drugs. He C; Yin L; Tang C; Yin C Biomaterials; 2012 Nov; 33(33):8569-78. PubMed ID: 22906606 [TBL] [Abstract][Full Text] [Related]
29. Bioimaging of Intact Polycaprolactone Nanoparticles Using Aggregation-Caused Quenching Probes: Size-Dependent Translocation via Oral Delivery. He H; Xie Y; Lv Y; Qi J; Dong X; Zhao W; Wu W; Lu Y Adv Healthc Mater; 2018 Nov; 7(22):e1800711. PubMed ID: 30345713 [TBL] [Abstract][Full Text] [Related]
30. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles. Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754 [TBL] [Abstract][Full Text] [Related]
31. Preparation of albumin based nanoparticles for delivery of fisetin and evaluation of its cytotoxic activity. Ghosh P; Singha Roy A; Chaudhury S; Jana SK; Chaudhury K; Dasgupta S Int J Biol Macromol; 2016 May; 86():408-17. PubMed ID: 26820351 [TBL] [Abstract][Full Text] [Related]
32. Mechanisms of nanoparticle internalization and transport across an intestinal epithelial cell model: effect of size and surface charge. Bannunah AM; Vllasaliu D; Lord J; Stolnik S Mol Pharm; 2014 Dec; 11(12):4363-73. PubMed ID: 25327847 [TBL] [Abstract][Full Text] [Related]
33. Albumin-based nanoparticles as potential controlled release drug delivery systems. Elzoghby AO; Samy WM; Elgindy NA J Control Release; 2012 Jan; 157(2):168-82. PubMed ID: 21839127 [TBL] [Abstract][Full Text] [Related]
34. Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes. Truzzi E; Bongio C; Sacchetti F; Maretti E; Montanari M; Iannuccelli V; Vismara E; Leo E Molecules; 2017 Jun; 22(6):. PubMed ID: 28598368 [TBL] [Abstract][Full Text] [Related]
35. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination. Slütter B; Plapied L; Fievez V; Sande MA; des Rieux A; Schneider YJ; Van Riet E; Jiskoot W; Préat V J Control Release; 2009 Sep; 138(2):113-21. PubMed ID: 19445980 [TBL] [Abstract][Full Text] [Related]
36. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency. Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400 [TBL] [Abstract][Full Text] [Related]
37. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer. Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi YW; Choi HG; Park ES; Lee KC; Youn YS Pharm Res; 2016 Mar; 33(3):615-26. PubMed ID: 26526555 [TBL] [Abstract][Full Text] [Related]
38. Facilitated nanoscale delivery of insulin across intestinal membrane models. Woitiski CB; Sarmento B; Carvalho RA; Neufeld RJ; Veiga F Int J Pharm; 2011 Jun; 412(1-2):123-31. PubMed ID: 21501675 [TBL] [Abstract][Full Text] [Related]
39. Mechanism of hepatic targeting via oral administration of DSPE-PEG-cholic acid-modified nanoliposomes. Li Y; Zhu C Int J Nanomedicine; 2017; 12():1673-1684. PubMed ID: 28280334 [TBL] [Abstract][Full Text] [Related]